Frazier Life Sciences Management, L.P.
PALO ALTO, CA · CIK 1892134 · 13F filing filed 2026-08-14
SEC-registered investment adviser since 2021 · limited partnership
- Assets managed$7.0bn
- Staff64 · 47 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds8 (1 hedge) · $7.0bn gross assets
- Websitefrazierls.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityFrazier Life Sciences Management, L.P. (US)
- Kindhedge funds, private equity, venture
- Others nearbyPalo Alto, CA, San Diego, CA
As an employer
- Offices in1 country
- Private fundsventure capital 4, hedge 1, private equity 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Palo Alto, CA (main office)United States | about 44 |
| San Diego, CAUnited States | 3 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$4.6bn
reported value
+18.2% vs Q1 2026
41positions
73.6%in top 10
6 new
8 added
2 reduced
3 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| MIRUM PHARMACEUTICALS INC MIRM | $899.1m19.58% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $613.0m13.35% | Added +1.1m |
| ERASCA INC ERAS | $457.5m9.96% | Added +300.0k |
| MBX BIOSCIENCES INC MBX | $367.2m8.00% | Unchanged |
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $258.9m5.64% | Unchanged |
| TREVI THERAPEUTICS INC TRVI | $185.4m4.04% | Reduced -100 |
| KRYSTAL BIOTECH INC KRYS | $178.9m3.90% | Unchanged |
| MAZE THERAPEUTICS INC MAZE | $150.2m3.27% | Added +465.6k |
| PHATHOM PHARMACEUTICALS INC PHAT | $135.3m2.95% | Unchanged |
| PALVELLA THERAPEUTICS INC NE PVLA | $134.8m2.94% | Unchanged |
| BRIDGEBIO PHARMA INC BBIO | $115.3m2.51% | Reduced -1.9m |
| DISC MEDICINE INC IRON | $99.1m2.16% | Unchanged |
| CYTOKINETICS INC CYTK | $98.8m2.15% | Unchanged |
| DYNE THERAPEUTICS INC DYN | $70.0m1.53% | Unchanged |
| ASCENDIS PHARMA A/S SPONSORED ADR | $60.1m1.31% | Added +91.8k |
| SAVARA INC SVRA | $59.9m1.30% | Unchanged |
| PARABILIS MEDICINES INC PBLS | $52.6m1.14% | New |
| AURA BIOSCIENCES INC AURA | $50.4m1.10% | Added +2.0m |
| ACHIEVE LIFE SCIENCES INC ACHV | $49.7m1.08% | New |
| VOR BIOPHARMA INC VOR | $46.8m1.02% | Unchanged |
| ALLOGENE THERAPEUTICS INC ALLO | $46.7m1.02% | Added +18.6m |
| TARSUS PHARMACEUTICALS INC TARS | $45.9m1.00% | Unchanged |
| BIOCRYST PHARMACEUTICALS INC BCRX | $40.1m0.87% | Unchanged |
| ALKERMES PLC ALKS | $36.7m0.80% | Unchanged |
| ACADIA PHARMACEUTICALS INC ACAD | $36.4m0.79% | Unchanged |
| ZAI LAB LTD ZLAB | $36.1m0.79% | Unchanged |
| MANNKIND CORP MNKD | $28.1m0.61% | Added +700.0k |
| DESIGN THERAPEUTICS INC DSGN | $26.2m0.57% | New |
| ACLARIS THERAPEUTICS INC ACRS | $26.1m0.57% | Unchanged |
| SHATTUCK LABS INC STTK | $26.0m0.57% | New |
| KAILERA THERAPEUTICS INC KLRA | $24.2m0.53% | New |
| MONTE ROSA THERAPEUTICS INC GLUE | $24.2m0.53% | Unchanged |
| LEXEO THERAPEUTICS INC LXEO | $22.5m0.49% | Added +400.0k |
| RELAY THERAPEUTICS INC RLAY | $19.0m0.41% | New |
| EVOLUS INC EOLS | $18.3m0.40% | Unchanged |
| IMMUNOCORE HLDGS PLC IMCR | $15.4m0.34% | Unchanged |
| VALNEVA SE VALN | $12.0m0.26% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMSW | $10.7m0.23% | Unchanged |
| AUTOLUS THERAPEUTICS PLC AUTL | $7.1m0.15% | Unchanged |
| XILIO THERAPEUTICS INC XLO | $4.0m0.09% | Unchanged |
| IBIO INC IBIO | $3.4m0.07% | Unchanged |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| KALVISTA PHARMACEUTICALS INC KALV | $99.9m5.0m shares |
| REVOLUTION MEDICINES INC RVMD | $65.7m675.7k shares |
| AGIOS PHARMACEUTICALS INC AGIO | $42.5m1.3m shares |